These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24879326)

  • 21. Rituximab Therapy for Recalcitrant Idiopathic Sclerosing Orbital Inflammation.
    Yazici B; Cekic S; Yalcinkaya U; Kilic SS
    Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3):e91-e97. PubMed ID: 33060512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraorbital injection of rituximab: a new approach for active thyroid-associated orbitopathy, a prospective case series.
    Savino G; Balia L; Colucci D; Battendieri R; Gari M; Corsello SM; Pontecorvi A; Dickmann A
    Minerva Endocrinol; 2013 Jun; 38(2):173-9. PubMed ID: 23732371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of orbital inflammation in internal medicine: a retrospective case series of 29 patients].
    Abad S; Badelon I; Le Toumelin P; Warzocha U; Gambier N; Larroche C; Morax S; Dhôte R
    Rev Med Interne; 2012 Feb; 33(2):69-75. PubMed ID: 22217923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and Safety of Rituximab in Systemic Lupus Erythematosus: A Case Series Describing the Experience of 2 Centers.
    Gómez VJ; Carrión-Barberá I; Salman Monte TC; Acosta A; Torrente-Segarra V; Monfort J
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 2):391-395. PubMed ID: 30522941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).
    Maritati F; Fenoglio R; Pillebout E; Emmi G; Urban ML; Rocco R; Nicastro M; Incerti M; Goldoni M; Trivioli G; Silvestri E; Mohammad AJ; Jayne D; Eriksson P; Segelmark M; Novikov P; Harris H; Roccatello D; Vaglio A
    Arthritis Rheumatol; 2018 Jan; 70(1):109-114. PubMed ID: 28973844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of rituximab in patients with Graves' orbitopathy: a retrospective multicenter nationwide study.
    Deltour JB; d'Assigny Flamen M; Ladsous M; Giovansili L; Cariou B; Caron P; Drui D; Lebranchu P
    Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):2013-2021. PubMed ID: 32405700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.
    Delli K; Haacke EA; Kroese FG; Pollard RP; Ihrler S; van der Vegt B; Vissink A; Bootsma H; Spijkervet FK
    Ann Rheum Dis; 2016 Nov; 75(11):1933-1938. PubMed ID: 26757748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
    Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
    Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rituximab and hypogammaglobulinemia].
    Fernández Romero DS; Torre MG; Larrauri BJ; Malbrán E; Juri MC; Malbrán A
    Medicina (B Aires); 2015; 75(5):319-23. PubMed ID: 26502469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The preliminary observation of intralesional rituximab administration in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma].
    Yang JP; Pang X; Zhang K; Wang LL; Zhu Y
    Zhonghua Yan Ke Za Zhi; 2020 Nov; 56(11):839-845. PubMed ID: 33152842
    [No Abstract]   [Full Text] [Related]  

  • 32. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
    Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
    Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab induces distinct intraorbital and intrathyroidal effects in one patient satisfactorily treated for Graves' ophthalmopathy.
    Bonara P; Vannucchi G; Campi I; Rossi S; Cantoni F; Frugoni C; Sbrozzi F; Guastella C; Avignone S; Beck-Peccoz P; Salvi M
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):118-23. PubMed ID: 18270865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intralesional or intraorbital rituximab injection for the management of biopsy-proven idiopathic orbital inflammation involving the lacrimal gland.
    Demirci H; Ciftci S; Teo HMT; Demirci FY; Shinder R; Elner VM
    Can J Ophthalmol; 2023 Nov; ():. PubMed ID: 37995759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of refractory polyarteritis nodosa successfully treated with rituximab.
    Seri Y; Shoda H; Hanata N; Nagafuchi Y; Sumitomo S; Fujio K; Yamamoto K
    Mod Rheumatol; 2017 Jul; 27(4):696-698. PubMed ID: 25671401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
    Van Horebeek I; Knops N; Van Dyck M; Levtchenko E; Mekahli D
    Acta Clin Belg; 2017 Jun; 72(3):147-155. PubMed ID: 27409338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
    Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies.
    Ayan G; Esatoglu SN; Hatemi G; Ugurlu S; Seyahi E; Melikoglu M; Fresko I; Ozdogan H; Yurdakul S; Hamuryudan V
    Rheumatol Int; 2018 Apr; 38(4):607-622. PubMed ID: 29322343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients.
    van Dam LS; Oskam JM; Kamerling SWA; Arends EJ; Bredewold OW; Berkowska MA; van Dongen JJM; Rabelink TJ; van Kooten C; Teng YKO
    Front Immunol; 2020; 11():566732. PubMed ID: 33384685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
    Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
    Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.